Elevated extracellular matrix production and degradation upon bone morphogenetic protein-2 (BMP-2) stimulation point toward a role for BMP-2 in cartilage repair and remodeling
Open Access
- 8 October 2007
- journal article
- research article
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 9 (5) , 1-11
- https://doi.org/10.1186/ar2305
Abstract
Bone morphogenetic protein-2 (BMP-2) has been proposed as a tool for cartilage repair and as a stimulant of chondrogenesis. In healthy cartilage, BMP-2 is hardly present, whereas it is highly expressed during osteoarthritis. To assess its function in cartilage, BMP-2 was overexpressed in healthy murine knee joints and the effects on proteoglycan (PG) synthesis and degradation were evaluated. Moreover, the contribution of BMP in repairing damage induced by interleukin-1 (IL-1) was investigated. Ad-BMP-2 was injected intra-articularly into murine knee joints, which were isolated 3, 7, and 21 days after injection for histology, immunohistochemistry, and autoradiography. In addition, patellar and tibial cartilage was isolated for RNA isolation or measurement of PG synthesis by means of 35SO42- incorporation. To investigate the role for BMP-2 in cartilage repair, cartilage damage was induced by intra-articular injection of IL-1. After 2 days, Ad-BMP-2, Ad-BMP-2 + Ad-gremlin, Ad-gremlin, or a control virus was injected. Whole knee joints were isolated for histology at day 4 or patellae were isolated to measure 35SO42- incorporation. BMP-2 stimulated PG synthesis in patellar cartilage on all days and in tibial cartilage on day 21. Aggrecan mRNA expression had increased on all days in patellar cartilage, with the highest increase on day 7. Collagen type II expression showed a similar expression pattern. In tibial cartilage, collagen type II and aggrecan mRNA expression had increased on days 7 and 21. BMP-2 overexpression also induced increased aggrecan degradation in cartilage. VDIPEN staining (indicating matrix metalloproteinase activity) was elevated on day 3 in tibial cartilage and on days 3 and 7 in patellar cartilage, but no longer was by day 21. Increased NITEGE staining (indicating aggrecanase activity) was found on days 7 and 21. In IL-1-damaged patellar cartilage, BMP-2 boosted PG synthesis. Blocking of BMP activity resulted in a decreased PG synthesis compared with IL-1 alone. This decreased PG synthesis was associated with PG depletion in the cartilage. These data show that BMP-2 boosts matrix turnover in intact and IL-damaged cartilage. Moreover, BMP contributes to the intrinsic repair capacity of damaged cartilage. Increased matrix turnover might be functional in replacing matrix molecules in the repair of a damaged cartilage matrix.Keywords
This publication has 35 references indexed in Scilit:
- Update on the biology of the chondrocyte and new approaches to treating cartilage diseasesBest Practice & Research Clinical Rheumatology, 2006
- Pro-inflammatory Cytokine Tumor Necrosis Factor-α Induces Bone Morphogenetic Protein-2 in Chondrocytes via mRNA Stabilization and Transcriptional Up-regulationJournal of Biological Chemistry, 2006
- Regional gene therapy for full‐thickness articular cartilage lesions using naked DNA with a collagen matrixJournal of Orthopaedic Research, 2006
- Cartilage tissue engineering using human auricular chondrocytes embedded in different hydrogel materialsJournal of Biomedical Materials Research Part A, 2006
- BMP Receptor Signaling Is Required for Postnatal Maintenance of Articular CartilagePLoS Biology, 2004
- BMP2 initiates chondrogenic lineage development of adult human mesenchymal stem cells in high-density cultureDifferentiation, 2003
- Bone Morphogenetic Protein Signals Are Required for Cartilage Formation and Differently Regulate Joint Development During SkeletogenesisJournal of Bone and Mineral Research, 2002
- A two-component expression system that responds to inflammatory stimuli in vivoNature Biotechnology, 1997
- Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints.Journal of Clinical Investigation, 1997
- In vivo effects of interleukin‐1 on articular cartilage. Prolongation of proteoglycan metabolic disturbances in old miceArthritis & Rheumatism, 1991